Poor responder-high responder: the importance of soluble vascular endothelial growth factor receptor 1 in ovarian stimulation protocols.
about
Different ovarian stimulation protocols for women with diminished ovarian reserveRegulation of soluble vascular endothelial growth factor receptor (sFlt-1/sVEGFR-1) expression and release in endothelial cells by human follicular fluid and granulosa cellsChanges in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation.Blood and lymphatic vasculature in the ovary: development, function and disease.BMSCs reduce rat granulosa cell apoptosis induced by cisplatin and perimenopause.Lipid profiling of follicular fluid from women undergoing IVF: young poor ovarian responders versus normal responders.Vascular endothelial growth factor in females of reproductive age.Prediction and diagnosis of poor ovarian response: the dilemma.Comparative multiplex analysis of cytokines, chemokines and growth factors in follicular fluid of normoresponder women undergoing ovum donation with gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist protocols.Angiopoietin-1 and angiopoietin-2 are altered in polycystic ovarian syndrome (PCOS) during controlled ovarian stimulationDifferential long non-coding RNA expression profiles in human oocytes and cumulus cells.Follicular fluid PlGF/sFlt-1 ratio and soluble receptor for advanced glycation end-products correlate with ovarian sensitivity index in women undergoing A.R.T.Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF.Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
P2860
Q24634342-4CBD7C96-9334-4354-A9A3-8EE47397E79DQ24813046-91939848-B33D-4BDC-90B3-3483F6A5774FQ33729704-FFD87F4C-A251-427B-9B17-ADA977268ECCQ34375633-50DA92A4-DFEF-41E9-8BB1-51A92FD093A2Q34627468-52E8D144-4C5B-4982-9393-93D32E4B7F2BQ35057481-32CB8053-56EB-492F-A1A6-B80BEB409810Q35678769-5A5796EB-6420-4FC2-9890-260DFFE7AE4BQ37035196-EBBDEACC-687E-4019-BCB4-3EC2C59AADCAQ37370067-76EDA30E-291B-440E-B221-54F3028A33E9Q37493521-C67CA0D7-8D59-4D2C-AADE-0B71E2DFBD22Q48502044-E0D9FE70-9101-454D-8E90-4FA001740ED6Q48541058-336E4CD1-DA34-4B36-AE9B-DD7A071D0F27Q48723425-23D9E187-C690-4094-B957-A87FF8BCEC99Q50652388-A4545824-34BB-4B71-9FB6-BA670596F9C3
P2860
Poor responder-high responder: the importance of soluble vascular endothelial growth factor receptor 1 in ovarian stimulation protocols.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Poor responder-high responder: ...... ovarian stimulation protocols.
@en
Poor responder-high responder: ...... ovarian stimulation protocols.
@nl
type
label
Poor responder-high responder: ...... ovarian stimulation protocols.
@en
Poor responder-high responder: ...... ovarian stimulation protocols.
@nl
prefLabel
Poor responder-high responder: ...... ovarian stimulation protocols.
@en
Poor responder-high responder: ...... ovarian stimulation protocols.
@nl
P2093
P356
P1433
P1476
Poor responder-high responder: ...... ovarian stimulation protocols.
@en
P2093
Grunwald K
Weissenborn U
P304
P356
10.1093/HUMREP/16.4.621
P407
P577
2001-04-01T00:00:00Z